Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lidocaine,Heparin Sodium
Therapeutic Area : Urology
Study Phase : Phase II
Sponsor : Hyloris Pharmaceuticals
Deal Size : $6.7 million
Deal Type : Collaboration
Details : Under the terms of the agreement, Vaneltix will be responsible for the further development, manufacturing, regulatory affairs and commercialisation of AlenuraTM in collaboration with Hyloris.
Product Name : Alenura
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
December 17, 2021
Lead Product(s) : Lidocaine,Heparin Sodium
Therapeutic Area : Urology
Highest Development Status : Phase II
Sponsor : Hyloris Pharmaceuticals
Deal Size : $6.7 million
Deal Type : Collaboration